“The [iLink​​ cross-linking] procedure is FDA-approved, and there is broad commercial insurance coverage for the procedure. It is important to diagnose keratoconus early (starting at late teens) and receive treatment if progression is noted as soon as possible”

– Dr. Douglas Katsev, Santa Barbara Eyecare

If you have been diagnosed with progressive keratoconus, your physician may have recommended the FDA-approved iLink​​ cross-linking procedure. If you are not familiar with iLink, it is a minimally invasive outpatient procedure for the treatment of progressive keratoconus. The goal of the procedure is to slow or halt the progression of the condition to help preserve vision. In California, Dr. Douglas Katsev, Founder and Surgical Director of Santa Barbara Eyecare, is one of the physicians performing this treatment.

Dr. Katsev recently spoke to the Santa Barbara News-Press about his experience treating his progressive KC patient, Andrea, with iLink. Before being treated, Andrea’s vision was affecting his ability to play soccer. He was having trouble seeing the blackboard in class and difficulty driving at night. He was very worried about his vision and knew he needed to do something about it. He was then diagnosed with progressive keratoconus, an eye condition in which the cornea weakens and thins over time, causing the development of a cone-like bulge and optical irregularity of the cornea which can result in significant visual loss. After consulting with Dr. Katsev and learning about iLink, Andrea decided to undergo the procedure. He has since recovered and is now back to playing soccer!

To hear more from Dr. Katsev, you can read the full article here. For additional information on keratoconus and FDA-approved iLink cross-linking, or to read personal keratoconus journeys, follow Living with KC on Twitter, Instagram, and Facebook.

Find a Cross-Linking Expert Near You

Search the directory to locate a cross-linking expert who is familiar with treating progressive keratoconus.

The results described on this site are based on data collected regarding short- and intermediate-term efficacy of treatment. Individual results are not guaranteed and may vary.

PM-US-0972